Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK

Published:2022-08 Issue:8 Volume:192 Page:1186-1198
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Zhang Qian,Wang Hong Y.,Nayak Anindita^ORCID,Nunez-Cruz Selene,Slupianek Artur,Liu Xiaobin,Basappa Johnvesly,Fan Jing-Song,Chekol Seble,Nejati Reza^ORCID,Bogusz Agata M.,Turner Suzanne D.,Swaminathan Kunchithapadam,Wasik Mariusz A.

Funder

Fox Chase Cancer Center

University of Pennsylvania Perelman School of Medicine

Abramson Cancer Center

National University of Singapore

Ministry of Education - Singapore

National Cancer Institute

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference50 articles.

1. Anaplastic lymphoma kinase is required for neurogenesis in the developing central nervous system of zebrafish;Yao;PLoS One,2013

2. Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas;Boi;Br J Haematol,2015

3. The next-generation ALK inhibitors;Pall;Curr Opin Oncol,2015

4. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target;Werner;Blood,2017

5. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma;Morris;Science,1994

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications;Frontiers in Oncology;2024-04-03

2. Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function;Leukemia;2023-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3